Contract packagers must adapt to surge in serialisation

By Nick Taylor

- Last updated on GMT

Related tags Service provider

Contract packagers must adapt to surge in serialisation
Contract packagers will lose deals if they fail to adapt to biopharm outsourcing “more and more” serialisation work, according to CEO of Covectra.

Proposed serialisation legislation would place additional requirements on biopharm and, in all likelihood, drive demand for service providers capable of handling the work. Increased demand presents a revenue opportunity for contract packagers but there are also challenges and risks.

Contract packagers must be flexible enough to meet the needs of different clients, from the big pharma with its own serialisation numbers to the biotech looking for an end-to-end service, Steve Wood, CEO of Covectra, told Outsourcing-Pharma.

Failure to meet these needs will result in loss of contracts, said Wood. This will begin happening “very soon​” as biopharm launches pilot projects ahead of the “huge, huge undertaking​” of serialising full product portfolios.

Related news

Show more

Related products

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

The Complete Guide to eRegulatory and eSource

The Complete Guide to eRegulatory and eSource

Content provided by Florence Healthcare | 01-Apr-2023 | Insight Guide

Shifting to eRegulatory and eSource workflows is a requirement for clinical trial sites to continue to scale and grow their studies. This guide is designed...

Follow us

Products

View more

Webinars